New Key Statistics Module, Z-Score and F-Score
OTCPK:SNPHY Key Ratios
Market Cap $ M | 4,457.58 |
Enterprise Value $ M | 3,792.93 |
P/E(ttm) | 23.41 |
PE Ratio without NRI | 23.41 |
Forward PE Ratio | 20.14 |
Price/Book | 2.08 |
Price/Sales | 2.08 |
Price/Free Cash Flow | 8.58 |
Price/Owner Earnings | 14.84 |
Payout Ratio % | 0.43 |
Revenue (TTM) $ M | 2,033.00 |
EPS (TTM) $ | 0.50 |
Beneish M-Score | -3.13 |
10-y EBITDA Growth Rate % | -3.50 |
5-y EBITDA Growth Rate % | -9.60 |
y-y EBITDA Growth Rate % | 312.20 |
EV-to-EBIT | 15.41 |
EV-to-EBITDA | 9.88 |
PEG | -- |
Shares Outstanding M | 350.04 |
Net Margin (%) | 8.83 |
Operating Margin % | 12.80 |
Pre-tax Margin (%) | 10.01 |
Quick Ratio | 2.08 |
Current Ratio | 2.54 |
ROA % (ttm) | 6.31 |
ROE % (ttm) | 8.91 |
ROIC % (ttm) | 11.20 |
Dividend Yield % | 1.68 |
Altman Z-Score | 4.94 |
SNPHY Number of Guru Trades
SNPHY Volume of Guru Trades
Gurus Latest Trades with OTCPK:SNPHY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SNPHY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Santen Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:SNPHY
Total 0- 1